The Androgen Deprivation Therapy ADT Market size is expected to grow at an annual average of 5% during 2021-2027. Androgen deprivation therapy (ADT), also known as androgen suppression therapy, is administered to men with prostate cancer. The pancreas is an androgen-dependent organ, and by providing ADT, it can provide treatment for advanced and metastatic disease. […]
